Target intelligence / Profile preview

ATPase H+ transporting V0 subunit e1 pseudogene 2 (ATP6V0E1P2)

Target
ATP6V0E1P2
Molecular classification
Pseudogene, Non-coding RNA (processed pseudogene; retrocopy)
01

Overview

ATP6V0E1P2 is a human processed pseudogene located on chromosome 3[9], derived as a retrocopy of the ATP6V0E1 gene[7][9]. ATP6V0E1 itself encodes a V0 subunit e1 of the vacuolar ATPase (V-ATPase), an enzyme involved in proton transport across lysosomal and vacuolar membranes. However, ATP6V0E1P2 is a non-functional genomic element and does not produce a protein. While some pseudogenes have been shown to participate in gene regulation via their RNA transcripts, no regulatory or disease-related roles for ATP6V0E1P2 have been described in the literature or genetic databases. As such, it is not considered a molecular target for therapeutic intervention[1][3][4][5][7][8][9].\n\nATP6V0E1P2 is a pseudogene (non-coding, retrocopy) of ATP6V0E1, not a canonical therapeutic target, not associated with any known drug interactions, disease roles, or safety issues, and lacks an established biological function[1][3][4][5][7][8][9].

Other names
ATP6V0E1P2ATPase H+ transporting lysosomal 9kDa V0 subunit e1 pseudogene 2
02

Mechanism of action

None. There are no mechanisms of action described for ATP6V0E1P2, as it is not a drug target

03

Biological functions

None established for ATP6V0E1P2. Pseudogenes can occasionally have regulatory roles as RNA (e.g., acting as decoys for microRNAs), but there is no evidence in public resources or literature that ATP6V0E1P2 is biologically active
04

Disease associations

None established. While some pseudogenes have been implicated in regulatory functions in cancer or other diseases, there is no evidence implicating ATP6V0E1P2 in any disease process
05

Safety considerations

None. There are no safety concerns or therapeutic challenges associated with this pseudogene
06

Interacting drugs

None. There are no drugs known to interact with ATP6V0E1P2, as it does not encode a protein or functional RNA that binds drugs
07

Biomarkers

None known. ATP6V0E1P2 is not used as a biomarker for patient selection or therapeutic monitoring

Beyond the preview

Go deeper on ATPase H+ transporting V0 subunit e1 pseudogene 2 (ATP6V0E1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATPase H+ transporting V0 subunit e1 pseudogene 2 (ATP6V0E1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call